Biosample Repository Study

Lawrence S Kirschner, M.D., Ph.D. has recently joined the NIEHS as the new Medical Director of the Clinical Research Unit and member of the CRB. Dr. Kirschner obtained his undergraduate degree from Princeton University, followed by dual-degree training at the Albert Einstein College of Medicine. During his PhD, he studied mechanisms of multidrug resistance in cancer cells in the lab of Dr. Susan Horwitz. After completing a residency in Internal Medicine at the University of Minnesota, he moved to the NIH in Bethesda for a clinical fellowship in Endocrinology, followed by 3 years as a Staff Scientist. While there, he worked in the group of Dr. Constantine Stratakis, where he identified the gene causing the inherited tumor syndrome Carney Complex and began molecular characterization of its tumorigenic function. In 2002, he established his independent research program at The Ohio State University, where he continued his studies of molecular mechanisms of carcinogenesis associated with inherited endocrine tumor syndromes funded by the NIH and other national organizations. He maintained an active clinical practice during his time at Ohio State, and is recognized nationally and internationally as an expert in adrenal diseases and inherited tumor syndromes. He is also a well-established clinical researcher dating back to his days in Bethesda, and he has been a site PI for trials of new agents to treat endocrine disorders, including many which are now FDA approved. Lastly, he has a strong interest in education and mentoring, serving as as director of the Ohio State MD-PhD training program for over 10 years and being appointed as Associate Director of Education and Training at the OSU Comprehensive Cancer Center. He brings this wealth of experience and expertise to the leadership of our CRU. He will also serve as Director of Clinical and Laboratory Sciences for the PEGS program and devote some of his time to continuing his molecular studies of endocrine tumor formation.